Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

por Javier Escalada, F., Halimi, Serge, Senior, Peter A., Bonnemaire, Mireille, Cali, Anna M. G., Melas‐Melt, Lydie, Karalliedde, Janaka, Ritzel, Robert A.
Publicado 2018